Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | IKBKB | O14920 | 1/20 | 0.49 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | USP28 | Q96RU2 | 6/20 | 0.46 |
| ▸ | USP25 | Q9UHP3 | 6/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | PTPRC | P08575 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13926046 | 0.85 | PTPN1 (0.45) | KDM4EPKMHTTPTPN1PTPN2 | |
| SCHEMBL13950062 | 0.83 | PTPN1 (0.45) | KDM4EPKMHTTPTPN1PTPN2 | |
| SCHEMBL4118398 | 0.82 | PTPN1 (0.53) | KDM4EPKMLIMK1PTPN1PTPN2 | |
| SCHEMBL4125907 | 0.81 | PTPN1 (0.43) | KDM4EPKMHTTPTPN1PTPN2 | |
| SCHEMBL13926043 | 0.79 | KDM4E (0.71) | KDM4EIKBKBLIMK1PTPN1PTPN2 | |
| SCHEMBL4120914 | 0.79 | KDM4E (0.43) | KDM4EPKMHTTPTPN1PTPN2 | |
| SCHEMBL4126271 | 0.79 | KDM4E (0.60) | KDM4EPTPN1PTPN2ALDH1A1NPSR1 | |
| Hydrochloric Acid SCHEMBL4126830 | 0.77 | PTPN1 (0.38) | KDM4EPKMHTTPTPN1PTPN2 | |
| Hydrochloric Acid SCHEMBL4131714 | 0.77 | PTPN1 (0.41) | KDM4EPKMHTTPTPN1PTPN2 | |
| SCHEMBL13926049 | 0.77 | IKBKB (0.50) | KDM4EPKMHTTIKBKBPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | WYETH (US) | 2009-02-19 | — | — | US | disclosed |
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | WYETH | 2005-09-15 | — | — | US | disclosed |
| WO-2005081960-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | WYETH (US) | 2005-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | PTPRS, PTPRO, PTPRM | KDM4E 899/4885PKM 2457/4885HTT 2323/4885 |
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | PTPRS, PTPRO, PTPRM | KDM4E 899/4885PKM 2457/4885HTT 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.